Citadel Advisors - INTRA CELLULAR THERAPIES INC ownership

Back to all holdings Add to watchlist

INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X951. A total of 3 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Citadel Advisors ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q2 2016$1,200,000
+114.7%
30,900
+53.7%
0.00%0.0%
Q1 2016$559,000
-24.2%
20,100
+46.7%
0.00%0.0%
Q4 2015$737,000
-9.3%
13,700
-32.5%
0.00%0.0%
Q3 2015$813,000
+162.3%
20,300
+109.3%
0.00%–
Q2 2015$310,000–9,700–0.00%–
 Download
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q3 2016
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 34,600$1,802,3140.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 8,300$4320.00%
View complete list of INTRA CELLULAR THERAPIES INC shareholders